drug
ivabradine hydrochloride
Marketedupdated 3mo agoby Ingenus Pharmaceuticals LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 22, 2026
29 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (20)
- Jun 12, 2027patentUS 7867996*PED323d
- Jun 12, 2027patentUS 7867996*PED323d
- Dec 12, 2026compositionUS 7867996141d
- Dec 12, 2026compositionUS 7867996141d
- Dec 12, 2026compositionUS 7867996141d
- Aug 22, 2026patentUS 7361649*PED29d
- Aug 22, 2026patentUS 7361649*PED29d
- Aug 22, 2026patentUS 7361650*PED29d
- Aug 22, 2026patentUS 7361650*PED29d
- Aug 22, 2026patentUS 7879842*PED29d
- Aug 22, 2026patentUS 7879842*PED29d
- Feb 22, 2026compositionUS 7361649
- Feb 22, 2026compositionUS 7361649
- Feb 22, 2026compositionUS 7361649
- Feb 22, 2026compositionUS 7361650
- Feb 22, 2026compositionUS 7361650
- Feb 22, 2026compositionUS 7361650
- Feb 22, 2026compositionUS 7879842
- Feb 22, 2026compositionUS 7879842
- Feb 22, 2026compositionUS 7879842
FDA exclusivities (2)
- Oct 22, 2026PEDPediatric (6mo bonus)90d
- Apr 22, 2026ODE-234Orphan Drug (7y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 49m ago
Found something off?
comments(0)
5-min edit window · permanent after that